Streetbeat News

Price Targets

ATEC

Needham analyst David Saxon has maintained a Buy rating on Alphatec Holdings (NASDAQ:ATEC) and increased the price target from $16 to $18.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 10:24 am

AMGN

BMO Capital analyst Evan David Seigerman has upgraded Amgen (NASDAQ:AMGN) from Market Perform to Outperform and increased the price target from $286 to $326.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 10:13 am

WWW

Telsey Advisory Group analyst Dana Telsey has reiterated a 'Market Perform' rating on Wolverine World Wide (NYSE:WWW) and maintained a $10 price target on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 10:08 am

EFX

Oppenheimer analyst Owen Lau has initiated coverage on Equifax (NYSE:EFX) with an Outperform rating and set a price target of $273.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:33 am

TRU

Oppenheimer analyst Owen Lau has initiated coverage on TransUnion (NYSE:TRU) with an Outperform rating and set a price target of $81 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:30 am

VTNR

Stifel analyst Michael Hoffman has downgraded Vertex Energy (NASDAQ:VTNR) from Buy to Hold and reduced the price target from $6 to $4. This reflects a more cautious stance on the company's stock by the analyst.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:23 am

SITE

Stifel analyst W. Andrew Carter has downgraded SiteOne Landscape Supply (NYSE:SITE) from Buy to Hold and set a price target of $167.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:20 am

QURE

Mizuho analyst Uy Ear has downgraded uniQure (NASDAQ:QURE) from Buy to Neutral and set a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:16 am

UBER

Keybanc analyst Justin Patterson has maintained an Overweight rating on Uber Technologies (NYSE:UBER) and increased the price target from $61 to $70, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:12 am

MIRM

Raymond James analyst Steven Seedhouse has maintained a Strong Buy rating on Mirum Pharmaceuticals (NASDAQ:MIRM) but has reduced the price target from $78 to $64.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 9:08 am